MAPT and Alzheimer disease: Application of SuStaIn to Aβ+ subjects recovered four of the five subtypes: ‘Typical AD Early Tau’, ‘Typical AD Late Tau’, ‘Cortical’ and ‘Cognitive’, whereas application of SuStaIn to Aβ− subjects recovered three of the five subtypes: ‘Cortical’, ‘Cognitive’ and ‘Subcortical’.